| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/06/1994 | EP0591057A1 Arylalkyl(thio)amides with melatonine receptor selectivity and process for their preparation |
| 04/06/1994 | EP0591040A1 Quaternary basic amides as tachykinines antagonists |
| 04/06/1994 | EP0590152A1 Peptides with tachykinin antagonist activity |
| 04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
| 04/06/1994 | EP0589985A1 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
| 04/06/1994 | EP0589951A1 Modified sialyl lewis?x compounds |
| 04/06/1994 | EP0589875A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
| 04/05/1994 | US5300648 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
| 04/05/1994 | US5300639 2-oxo-3-carbonylamino-substituted azepine intermediates; lipoperoxide formation inhibitors |
| 03/31/1994 | WO1994007142A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 03/31/1994 | WO1994006920A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | WO1994006828A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | WO1994006821A1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | WO1994006790A1 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes as paf receptor antgonists and inhibitors of 5-lipoxygenase |
| 03/31/1994 | WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006466A1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection |
| 03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 03/31/1994 | WO1994006454A2 Inhibitiion of retrovirus infection |
| 03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/31/1994 | WO1994006433A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 03/31/1994 | WO1994006431A1 Novel epoxide-containing compounds |
| 03/31/1994 | WO1994006430A1 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
| 03/31/1994 | WO1994006429A1 Compositions for treating allergic disorders using (-) cetirizine |
| 03/31/1994 | WO1994004691A3 Dimer and multimer forms of single chain polypeptides |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | DE4303818C1 Sterile medicament for topical admin. of dexpanthenol - contg. a polyacrylate carrier to improve stability of active agent |
| 03/31/1994 | CA2145413A1 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
| 03/31/1994 | CA2145410A1 Compositions for treating allergic disorders using (-) cetirizine |
| 03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
| 03/31/1994 | CA2145063A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | CA2144409A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
| 03/30/1994 | EP0589843A1 Pharmaceutical compositions containing cyclosporins |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589703A1 Proline derivative of rapamycin, production and application thereof |
| 03/30/1994 | EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter |
| 03/30/1994 | EP0589038A1 Tricyclic compound |
| 03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/30/1994 | EP0588859A1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use |
| 03/30/1994 | EP0588858A1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE |
| 03/30/1994 | EP0588852A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
| 03/30/1994 | EP0588848A1 Modified sialyl lewis?a compounds |
| 03/30/1994 | EP0588785A1 Urea based lipoxygenase inhibiting compounds |
| 03/30/1994 | EP0508993B1 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
| 03/30/1994 | CN1084515A Phenyl sulfonamide endothelin antagonists |
| 03/29/1994 | US5298621 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same |
| 03/29/1994 | US5298514 Phenolic thioetheramides |
| 03/29/1994 | US5298511 Alkanoic acid derivatives |
| 03/29/1994 | US5298490 Tetra and penta-peptides useful in regulating the immune system |
| 03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
| 03/25/1994 | CA2106034A1 21-norrapamycin |
| 03/23/1994 | EP0588655A1 Amidinophenol derivatives |
| 03/23/1994 | EP0588578A1 Immunogens |
| 03/23/1994 | EP0588430A1 (S)-(+)-Hydroxychloroquine |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587800A1 Immunomodulatory azaspiranes |
| 03/23/1994 | EP0587756A1 Novel immunosuppressive compounds |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587673A1 Derivatives of thiopyranopyrrole and preparation thereof |
| 03/23/1994 | CN1084175A Novel phospholipid derivatives |
| 03/23/1994 | CN1084166A Substituted (benzothiazolyl-and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
| 03/23/1994 | CN1084079A Ophthalmic compositions |
| 03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
| 03/22/1994 | US5296495 Thiazolylbenzofuran derivatives and pharmaceutical composition comprising the same |
| 03/22/1994 | US5296486 Leukotriene biosynthesis inhibitors |
| 03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/17/1994 | WO1994005531A1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
| 03/17/1994 | CA2143186A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/16/1994 | EP0587499A1 Benzopyran compounds, process for their preparation and their use as cell protectors |
| 03/16/1994 | EP0587137A1 Adsorbate comparised of an auxiliary agent mixture and a non-solid active agent for the manufacture of pharmaceutical preparations |
| 03/16/1994 | EP0587055A1 Use of manganese superoxide dismutase (Mn-SOD) in low dosage for the production of pharmaca for the treatment of diseases |
| 03/16/1994 | EP0586917A1 Substituted phenols, process for their preparation and their use in the treatment of all proliferation associated diseases |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586560A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
| 03/16/1994 | EP0586532A1 Method of using substance p to treat allergy |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | EP0586512A1 Use of rapamycin prodrugs as immunosuppressant agents |
| 03/16/1994 | EP0586486A1 Derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them |
| 03/16/1994 | CN1083704A Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| 03/16/1994 | CN1024006C Preparation method of ethynylheteroaromatic-acids having restinoic acid-like activity |
| 03/16/1994 | CA2104903A1 (s)-(+)-hydroxychloroquine |
| 03/15/1994 | US5294723 Antitumor, immunology |
| 03/15/1994 | US5294636 Such as zafirlukast; leukotriene antagonist; metered dose inhalers |
| 03/15/1994 | US5294626 Arylsulphonamides pharmaceutical compositions containing these compounds |
| 03/15/1994 | US5294623 (Benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma |
| 03/15/1994 | CA2105881A1 Compositions for the treatment and prophylaxis of metabolic disturbances in infants |
| 03/15/1994 | CA2105646A1 Use of therapeutic agent from mycobacterium vaccae against hiv infections with aids |
| 03/15/1994 | CA2105629A1 Potentiation of immunogenic response |
| 03/15/1994 | CA1327867C Peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same |
| 03/15/1994 | CA1327748C Pharmaceutical composition containing ranitidine and alginic acid |